Page last updated: 2024-12-10
epsilon-n-1-(1-deoxylactulosyl)lysine
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
epsilon-N-1-(1-deoxylactulosyl)lysine: beta-galactosidase substrate [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 3082392 |
MeSH ID | M0120454 |
Synonyms (8)
Synonym |
---|
34326-63-1 |
epsilon-(deoxylactulose)lysine |
lactulose-lysine |
d-fructose, 1-((5-amino-5-carboxypentyl)amino)-1-deoxy-4-o-beta-d-galactopyranosyl-, (s)- |
epsilon-n-1-(1-deoxylactulosyl)lysine |
lactuloselysine |
lactose-lysine |
2-amino-6-[[3,5,6-trihydroxy-2-oxo-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexyl]amino]hexanoic acid |
Research Excerpts
Bioavailability
Excerpt | Reference | Relevance |
---|---|---|
"Determination of the consequences of a high level of lactuloselysine in milk on the bioavailability of skim milk nutrients and the kinetics of their appearance in the portal blood and of their urinary and faecal excretions and extrapolation to lower heat treatments and to man, using the pig model." | ( Nutritional and metabolic consequences of the early Maillard reaction of heat treated milk in the pig. Significance for man. Calmes, R; Finot, PA; Rérat, A; Vaissade, P, 2002) | 0.31 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.37
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.37) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |